InsiderTrades.com logo
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

THAR Insider Trading

Insider Ownership Percentage: 2.37%
Insider Buying (Last 12 Months): $34,727.00
Insider Selling (Last 12 Months): $0.00

Tharimmune Insider Trading History Chart

This chart shows the insider buying and selling history at Tharimmune by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tharimmune Share Price & Price History

Current Price: $2.07
Price Change: ▼ Price Decrease of -0.03 (-1.43%)
As of 12/20/2024 06:30 PM ET

This chart shows the closing price history over time for THAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

Tharimmune Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2024Randy MilbyCEOBuy4,600$2.12$9,752.0017,534View SEC Filing Icon  
11/13/2024Sireesh AppajosyulaCOOBuy5,000$2.02$10,100.0010,758View SEC Filing Icon  
10/8/2024Randy MilbyCEOBuy2,500$2.09$5,225.0012,934View SEC Filing Icon  
10/8/2024Sireesh AppajosyulaCOOBuy5,000$1.93$9,650.0016,364View SEC Filing Icon  
12/15/2023Randy MilbyCEOBuy1,933$7.50$14,497.5010,434View SEC Filing Icon  
11/30/2023Randy MilbyCEOBuy666$15.00$9,990.008,501View SEC Filing Icon  
See Full Table
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

SEC Filings (Institutional Ownership Changes) for Tharimmune (NASDAQ:THAR)

1.16% of Tharimmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Tharimmune Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2024Curi RMB Capital LLC23,620$59K0.0%N/A2.056%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tharimmune logo
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics; and Washington University in St. Louis for the rights to develop and commercialize technology related to multiple hybridomas and antibodies directed specifically towards human HER2. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.
Read More on Tharimmune

Today's Range

Now: $2.07
Low: $2.07
High: $2.17

50 Day Range

MA: $2.29
Low: $1.92
High: $3.43

52 Week Range

Now: $2.07
Low: $1.84
High: $8.42

Volume

28,000 shs

Average Volume

353,038 shs

Market Capitalization

$3.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Tharimmune?

Tharimmune's top insider shareholders include:
  1. Randy Milby (CEO)
  2. Sireesh Appajosyula (COO)
Learn More about top insider investors at Tharimmune.

Who are the major institutional investors of Tharimmune?

Tharimmune's top institutional shareholders include:
  1. Curi RMB Capital LLC — 2.06%
Learn More about top institutional investors of Tharimmune stock.

Which major investors are buying Tharimmune stock?

During the last quarter, THAR stock was bought by institutional investors including:
  1. Curi RMB Capital LLC
Within the last year, these company insiders have bought Tharimmune stock:
  1. Randy Milby (CEO)
  2. Sireesh Appajosyula (COO)
Learn More investors buying Tharimmune stock.
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.